Catalyst Wire Dossier Catalyst Wire Dossier

Anti-TIM-3 antibody

TIM-3 antagonist
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-TIM-3 antibody, covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM [Phase 1]

See pricing